Thermo Fisher Completes Dionex Buy, Acquires Sterilin

The $2.1 billion Dionex purchase fills out Thermo Fisher's chromatography portfolio, while its acquisition of Sterilin broadens its specialty laboratory product portfolio.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories